Zhongkai Wang

Zhongkai Wang

Eli Lilly and Company - Indianapolis / United States
Natural Sciences / Mathematical Sciences
AD Scientific Index ID: 4385312
-
person_outline Zhongkai Wang's MOST POPULAR ARTICLES
1-) Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis Shock 49 (3), 249-258, 2018
2-) Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients Journal of Trauma and Acute Care Surgery 84 (2), 342-349, 2018
3-) The epidemiology of chronic critical illness after severe traumatic injury at two level–one trauma centers Critical care medicine 45 (12), 1989-1996, 2017
4-) The epidemiology of chronic critical illness after severe traumatic injury at two level–one trauma centersJC Mira, J Cuschieri, T Ozrazgat-Baslanti, Z Wang, GL Ghita, TJ Loftus, ...Critical care medicine 45 (12), 1989-1996, 20171122017
5-) Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsisMKK Hollen, JA Stortz, D Darden, ML Dirain, DC Nacionales, RB Hawkins, ...Critical Care 23, 1-16, 2019812019